Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,605Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M5.6EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)22.4Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.5PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100,000,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XLV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XLVKen Fisher 2016-06-30 Add$67.78 - $72.68
($70.43)
$ 73.114%Add 9.61%327,373
XLVKen Fisher 2016-03-31 Add$63.52 - $72.03
($67.02)
$ 73.119%Add 1.75%298,675
XLVKen Fisher 2015-12-31 Add$66.86 - $72.99
($70.76)
$ 73.113%Add 2.64%293,541
XLVKen Fisher 2015-09-30 Add$64.29 - $77.22
($73.06)
$ 73.110%Add 5.33%285,985
XLVLeon Cooperman 2015-06-30 Sold Out -0.42%$71.46 - $76.45
($73.85)
$ 73.11-1%Sold Out0
XLVKen Fisher 2015-06-30 Add$71.71 - $76.45
($74.07)
$ 73.11-1%Add 5.40%271,515
XLVLeon Cooperman 2015-03-31 Buy 0.42%$67.86 - $74.9
($71.15)
$ 73.113%New holding366,000
XLVKen Fisher 2015-03-31 Add$68.05 - $74.9
($71.32)
$ 73.113%Add 4.15%257,614
XLVKen Fisher 2014-06-30 Add0.01%$55.71 - $61.23
($58.7)
$ 73.1125%Add 34.36%226,412
XLVGeorge Soros 2012-09-30 Sold Out -0.03%$37.27 - $40.3
($38.73)
$ 73.1189%Sold Out0
XLVGeorge Soros 2012-06-30 Buy 0.03%$35.52 - $37.87
($36.91)
$ 73.1198%New holding50,000
XLVKen Fisher 2012-06-30 Add$35.52 - $37.87
($36.91)
$ 73.1198%Add 53.52%119,754
XLVKen Fisher 2011-06-30 Buy 0.01%$33.28 - $36.42
($34.99)
$ 73.11109%New holding86,997
XLVGeorge Soros 2011-03-31 Sold Out $31.5 - $33.18
($32.33)
$ 73.11126%Sold Out0
XLVGeorge Soros 2010-12-31 Reduce-0.15%$30.19 - $31.78
($31.13)
$ 73.11135%Reduce -93.88%34,153
XLVGeorge Soros 2010-09-30 Buy 0.25%$28.03 - $30.68
($29.2)
$ 73.11150%New holding558,053
XLVGeorge Soros 2010-06-30 Sold Out $28.38 - $32.31
($30.13)
$ 73.11143%Sold Out0
XLVGeorge Soros 2010-03-31 Reduce$30.68 - $33
($31.72)
$ 73.11130%Reduce -43.59%6,600
XLVGeorge Soros 2009-12-31 Buy 0.01%$28.07 - $31.62
($30.04)
$ 73.11143%New holding11,700
XLVBill Gates 2009-06-30 Sold Out -4.19%$23.76 - $26.53
($25.04)
$ 73.11192%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XLV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XLV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Keogh, WillemSenior Officer 2016-09-08Buy338$21.28243.56view
Sardo, Vincent JamesDirector 2016-09-08Sell1,500$43.0569.83view
Larson, Douglas RobertDirector, Senior Officer 2016-09-08Sell800$8.35775.57view
Fraser, AlisonDirector or Senior Officer of Insider or Subsidiar 2016-09-08Sell12,700$10.18618.17view
Brown, ArthurDirector 2016-09-08Sell250,000$0.07104342.86view
Brewster, NormanSenior Officer 2016-09-08Sell45,000$0.03243600view
Darling, Neil B.T.Director 2016-09-08Buy53,500$0.2726977.78view
Porter, Brian JDirector, Senior Officer 2016-09-08Sell25,176$70.174.19view
Marsh, John M.Director 2016-09-08Sell36,000$29.5147.83view
Graham, Eric JohnSenior Officer 2016-09-08Buy1,700$3.232163.47view

Quarterly/Annual Reports about XLV:

    News about XLV:

    Articles On GuruFocus.com
    S&P 500 Sector ETFs: A Look Under the Hood, Part 3 Mar 11 2015 
    Build a “Whatever Happens” Portfolio – Now! Aug 15 2014 
    Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

    More From Other Websites
    How’s Gilead Sciences Expected to Perform in 2016? Sep 22 2016
    Rise in Consumer Price Index Likely to Push Fed Rate Hike Sep 19 2016
    August Jobs Report: Labor Market’s Rapidly Changing Composition Sep 19 2016
    St. Jude Medical’s Stock Prices Are on a Declining Trend Sep 19 2016
    What Analysts Think about Bristol-Myers Squibb Sep 19 2016
    This Advisory Firm’s Name Held True to Form for St. Jude Medical Sep 16 2016
    Stop Wasting Energy On The VIX Sep 15 2016
    Stryker Acquires Ivy Sports Medicine to Strengthen Its Business Sep 15 2016
    The Case for Health Care Stocks (Especially Biotech) Sep 15 2016
    Price of pharma innovation: Pro Sep 15 2016
    Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial Sep 15 2016
    Executive Edge: Improving health care Sep 15 2016
    Why Is The Fed So Hesitant To Raise Interest Rates? Sep 12 2016
    Where to create alpha amid rising rates: Pro Sep 12 2016
    FDA Approves Medtronic’s Enlite Sensor for iPro2 CGM System Sep 09 2016
    Pfizer’s Essential Health Business: What You Need to Know Sep 09 2016
    Market Watches to See if Biogen Will Meet Its Raised Guidance Sep 09 2016
    What Are Analysts’ Recommendations for Perrigo in 2016? Sep 09 2016
    Analysts Look for Celgene to Offer Striking Returns in 2016 Sep 09 2016
    Rubenstein Thinks That Healthcare Spending Will Increase in the US Sep 09 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)